Home / News / Hatchtech gets lice treatment nod from FDA

Hatchtech gets lice treatment nod from FDA

02 August 2020

Posted in — News, The Australian Financial Review

Share

Read more from the Australian Financial Review below.

Learn more

Share

You may also like

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

Media Release

01 February 2018

No nit picking: Head lice group Hatchtech gets green light to trials

News, The Australian Financial Review

21 October 2014

Hatchtech announces successful results from Phase 2 ovicidal study

Media Release

01 November 2013

Hatchtech gets new VC backing for lice treatment trial

The Australian

View All

Ventured. Gained.

Subscribe to our Newsletter.

Name
This field is for validation purposes and should be left unchanged.
decor